241 related articles for article (PubMed ID: 25923835)
21. Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats.
Gratzke C; Strong TD; Gebska MA; Champion HC; Stief CG; Burnett AL; Bivalacqua TJ
J Urol; 2010 Nov; 184(5):2197-204. PubMed ID: 20851436
[TBL] [Abstract][Full Text] [Related]
22. Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury.
Fandel TM; Bella AJ; Lin G; Tantiwongse K; Lin CS; Pohl J; Lue TF
J Sex Med; 2008 Aug; 5(8):1866-75. PubMed ID: 18564148
[TBL] [Abstract][Full Text] [Related]
23. [Exogenous hydrogen sulfide improves erectile dysfunction by inhibiting apoptosis of corpus cavernosum smooth muscle cells in rats with cavernous nerve injury].
Zeng Q; He S; Zhong L; Wang L; Cheng F; Zhang H; Hui J; Wei A
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1329-1336. PubMed ID: 31852640
[TBL] [Abstract][Full Text] [Related]
24. Restoration of erectile function by a combination of antiapoptosis by JNK inhibitor and preservation of smooth muscle or endothelium by hepatocyte growth factor in a rat model of cavernous nerve injury.
Kim SW; Lee J; Oh S; Son H; Cho MC
Prostate; 2022 Jan; 82(1):49-58. PubMed ID: 34609772
[TBL] [Abstract][Full Text] [Related]
25. Intravenous Preload of Mesenchymal Stem Cells Rescues Erectile Function in a Rat Model of Cavernous Nerve Injury.
Takayanagi A; Sasaki M; Kataoka-Sasaki Y; Kobayashi K; Matsuda Y; Oka S; Masumori N; Kocsis JD; Honmou O
J Sex Med; 2015 Aug; 12(8):1713-21. PubMed ID: 26211660
[TBL] [Abstract][Full Text] [Related]
26. Both immediate and delayed intracavernous injection of autologous adipose-derived stromal vascular fraction enhances recovery of erectile function in a rat model of cavernous nerve injury.
Qiu X; Fandel TM; Ferretti L; Albersen M; Orabi H; Zhang H; Lin G; Lin CS; Schroeder T; Lue TF
Eur Urol; 2012 Oct; 62(4):720-7. PubMed ID: 22397847
[TBL] [Abstract][Full Text] [Related]
27. Restoration of Cavernous Veno-Occlusive Function through Chronic Administration of a Jun-Amino Terminal Kinase Inhibitor and a LIM-Kinase 2 Inhibitor by Suppressing Cavernous Apoptosis and Fibrosis in a Rat Model of Cavernous Nerve Injury: A Comparison with a Phosphodiesterase Type 5 Inhibitor.
Cho MC; Lee J; Park J; Kim SW
World J Mens Health; 2021 Jul; 39(3):541-549. PubMed ID: 32777863
[TBL] [Abstract][Full Text] [Related]
28. The Role of LIM Kinase in the Male Urogenital System.
Park J; Kim SW; Cho MC
Cells; 2021 Dec; 11(1):. PubMed ID: 35011645
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Jun N-terminal Kinase Improves Erectile Function by Alleviation of Cavernosal Apoptosis in a Rat Model of Cavernous Nerve Injury.
Park J; Chai JS; Kim SW; Paick JS; Cho MC
Urology; 2018 Mar; 113():253.e9-253.e16. PubMed ID: 29203189
[TBL] [Abstract][Full Text] [Related]
30. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats.
Canguven O; Lagoda G; Sezen SF; Burnett AL
J Urol; 2009 Jun; 181(6):2816-22. PubMed ID: 19375729
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effect of adipose-derived stem cells and BDNF-immobilized PLGA membrane in a rat model of cavernous nerve injury.
Piao S; Kim IG; Lee JY; Hong SH; Kim SW; Hwang TK; Oh SH; Lee JH; Ra JC; Lee JY
J Sex Med; 2012 Aug; 9(8):1968-79. PubMed ID: 22642440
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of intracavernous delivery of adenovirus encoding Smad7 gene on erectile function in a mouse model of cavernous nerve injury.
Song KM; Chung JS; Choi MJ; Jin HR; Yin GN; Kwon MH; Park JM; Kim WJ; Lee SJ; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2014 Jan; 11(1):51-63. PubMed ID: 24433558
[TBL] [Abstract][Full Text] [Related]
33. [Establishment of a rat model of erectile dysfunction after radical prostatectomy by crush injury or resection of the cavernous nerve].
Bian J; Dai YP; Sun XZ; Liu GH; Deng CH; Ye YL
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):230-3. PubMed ID: 21354899
[TBL] [Abstract][Full Text] [Related]
34. FTY720 Supplementation Partially Improves Erectile Dysfunction in Rats With Streptozotocin-Induced Type 1 Diabetes Through Inhibition of Endothelial Dysfunction and Corporal Fibrosis.
Cui K; Ruan Y; Wang T; Rao K; Chen Z; Wang S; Liu J
J Sex Med; 2017 Mar; 14(3):323-335. PubMed ID: 28162947
[TBL] [Abstract][Full Text] [Related]
35. Transplantation of Human Urine-Derived Stem Cells Transfected with Pigment Epithelium-Derived Factor to Protect Erectile Function in a Rat Model of Cavernous Nerve Injury.
Yang Q; Chen X; Zheng T; Han D; Zhang H; Shi Y; Bian J; Sun X; Xia K; Liang X; Liu G; Zhang Y; Deng C
Cell Transplant; 2016 Nov; 25(11):1987-2001. PubMed ID: 27075964
[TBL] [Abstract][Full Text] [Related]
36. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model.
Wu CC; Wu YN; Ho HO; Chen KC; Sheu MT; Chiang HS
J Sex Med; 2012 Nov; 9(11):2838-48. PubMed ID: 22906160
[TBL] [Abstract][Full Text] [Related]
37. Restoration of erectile function with intracavernous injections of endothelial progenitor cells after bilateral cavernous nerve injury in rats.
Liao CH; Wu YN; Lin YH; Syu Huang RF; Liu SP; Chiang HS
Andrology; 2015 Sep; 3(5):924-32. PubMed ID: 26311341
[TBL] [Abstract][Full Text] [Related]
38. Cavernous Nerve Injury by Radiation Therapy May Potentiate Erectile Dysfunction in Rats.
Mahmood J; Connors CQ; Alexander AA; Pavlovic R; Samanta S; Soman S; Matsui H; Sopko NA; Bivalacqua TJ; Weinreich D; Ho CY; Eley J; Sawant A; Jackson IL; Vujaskovic Z
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):680-688. PubMed ID: 29280463
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study.
Yuan J; Lin H; Li P; Zhang R; Luo A; Berardinelli F; Dai Y; Wang R
Eur Urol; 2010 Nov; 58(5):773-80. PubMed ID: 20674151
[TBL] [Abstract][Full Text] [Related]
40. Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure.
Oudot A; Behr-Roussel D; Poirier S; Sandner P; Bernabé J; Alexandre L; Giuliano F
Eur Urol; 2011 Nov; 60(5):1020-6. PubMed ID: 21839578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
